Jane Street’s Ventyx Biosciences VTYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-21,700
Closed -$196K 13125
2025
Q4
$196K Sell
21,700
-600
-3% -$4.48K ﹤0.01% 9741
2025
Q3
$69.4K Buy
+22,300
New +$59.1K ﹤0.01% 10259
2023
Q2
Sell
-32,500
Closed -$1.09M 9655
2023
Q1
$1.09M Buy
+32,500
New +$1.26M ﹤0.01% 4837
2022
Q4
Sell
-5,800
Closed -$202K 10244
2022
Q3
$202K Buy
+5,800
New +$128K ﹤0.01% 8168

Other funds holding VTYX

Jane Street's VTYX Position: Q1 2026 in Review

Jane Street sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 941,067 shares — an estimated $8.5M sold.

Jane Street first reported a position in VTYX in Q3 2022 and held it in 12 quarters. The position peaked at $8.5M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Jane Street reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 941,067 Ventyx Biosciences shares in Q1 2026, an estimated $8.5M.
  • Jane Street first reported a position in Ventyx Biosciences in Q3 2022 and held it in 12 quarters.
  • Jane Street's Ventyx Biosciences position peaked at $8.5M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.